Background:
Temporal artery (TA) biopsy has traditionally been considered the gold standard in the diagnosis of giant cell arteritis (GCA). Recently, the European League Against Rheumatism has recommended temporal+/- axillary artery ultrasound (US) as the first investigation in suspected GCA in centres with readily available high quality US1. However, not all centres have expertise in TA US.
Aim:
To assess the correlation between clinical assessment, TA biopsy and US in patients admitted with suspected GCA at Westmead Hospital, Sydney.
Methods:
This was a retrospective study between January 2011 and March 2020. A review of clinical notes, inflammatory markers (ESR and CRP), TA biopsy report and US results was performed. Pearson and Spearman correlation coefficients to assess the strength of association between variables will be used.
Interim results:
Fifty-six patients (20 male and 36 female, mean age 68.8) underwent TA US during the study period. Nine (16%) had positive sonographic findings. Thirty-seven patients underwent a TA biopsy. Nine of these had positive biopsy findings Compared to the gold standard of TA biopsy, the sensitivity and specificity of TA US was 77.8% and 92.8%, respectively. Of the 19 patients who had a TA US without a TA biopsy, only one had positive US findings and was empirically treated as GCA.
Interim conclusion:
Temporal artery US is a promising non-invasive investigation in the work-up of patients with suspected GCA. We have commenced a prospective study to assess its role in this patient group.